medigraphic.com
Órgano de Difusión de la Asociación Académica Panamericana de Medicina Familiar A.C.

2004, Number 3

<< Back

Arch Med Fam 2004; 6 (3)

The Impact of Neurocysticercosis in Developing Countries in Relation to Primary Health Care: Part Two

García-Morales E, Soriano-Sánchez JA.

Language: Spanish
References: 30
Page: 84-88
PDF size: 63.44 Kb.


Text Extraction

No abstract


REFERENCES

  1. Carpio A, Escobar A, Hauser WA. Cysticercosis and epilepsy: a critical review. Epilepsia 1998; 39: 1025-40.

  2. Monteiro L, Coelho T, Stocker A. Neurocysticercosis-a review of 231 cases. Infection 1992; 20: 61-5.

  3. WHO Fact Sheet N° 165. Revised February 2001.

  4. Senanayake N, Roman GC. Epidemiology of epilepsy in developing countries. Bull World Health Organ 1993; 71: 247-58.

  5. Sarti E, Schantz PM, Plancarte A et al. Epidemiological investigation of Taenia solium taeniasis and cysticercosis in a rural village of Michoacan State, Mexico. Trans R Soc Trop Med Hyg 1994; 88: 49-52.

  6. Garcia HH, Gilman R et al. Cysticercosis as a major cause of epilepsy in Peru. The Cysticercosis Working Group in Peru (CWG). Lancet 1993; 341(8839): 197-200.

  7. Medina M, Rosas E, Rubio F et al. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 1990; 150: 325-7.

  8. White AC. Neurocysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis 1997; 24: 101-15.

  9. Murthy JM, Yangala R. Etiological spectrum of symptomatic localization related epilepsies: a study from South India. J Neurol Sci 1998; 158(1): 65-70.

  10. Rigatti M, Trevisol-Bittencourt PC. Causes of late-onset epilepsy in an epilepsy clinic of Santa Catarina-Southern Brazil. Arq Neuropsiquiatr 1999; 57(3B): 787-92 [Article in Portuguese]. Abstract

  11. Valenca M, Andrade-Valen LP. Etiología das crises epilépticas na cidade de Recife, Brasil. Estudo de 249 pacientes. Arq Neuro Psiquiatr 2000; 58(4): 1064-1072.

  12. Nicoletti A et al. Epilepsy, cysticercosis, and toxocariasis: a population-based case-control study in rural Bolivia. Neurology 2002; 58(8): 1256-61.

  13. Schantz PM et al. Community-based epidemiological investigations of cysticercosis due to Taenia solium: comparison of serological screening tests and clinical findings in two populations in Mexico. Clin Infect Dis 1994; 18(6): 879-85.

  14. Garcia HH, Gilman RH et al. Clinical significance of neurocysticercosis in endemic villages. The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg 1997; 91(2): 176-8.

  15. Andriantsimahavandy A, Lesbordes JL et al. Neurocysticercosis: a major aetiological factor of late-onset epilepsy in Madagascar. Trop Med Int Health 1997; 2(8): 741-6.

  16. Balogou AA, Grunitzky KE et al. Cysticercosis and epilepsy in the City of Tone, North of Togo. Rev Neurol (Paris) 2000; 156(3): 270-3[Artículo en francés] Abstract.

  17. Wandra T, Subahar R et al. Resurgence of cases of epileptic seizures and burns associated with cysticercosis in Assologaima, Jayawijaya, Irian Jaya, Indonesia, 1991-95. Trans R Soc Trop Med Hyg 2000; 94(1): 46-50.

  18. Palacio LG, Jimenez I et al. Neurocysticercosis in persons with epilepsy in Medellin, Colombia. The Neuroepidemiological Research Group of Antioquia. Epilepsia 1998; 39(12): 1334-9.

  19. Garcia HH, Talley A et al. Epilepsy and neurocysticercosis in a village in Huaraz, Peru. Clin Neurol Neurosurg 1999; 101(4): 225-8.

  20. Singh G, Sachdev MS et al. Focal cortical-subcortical calcifications (FCSCs) and epilepsy in the Indian subcontinent. Epilepsia 2000; 41(6): 718-26.

  21. Garcia-Noval J, Moreno E et al. An epidemiological study of epilepsy and epileptic seizures in two rural Guatemalan communities. Ann Trop Med Parasitol 2001; 95(2): 167-75.

  22. Pal DK, Carpio A, Sander JW. Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry 2000; 68(2): 137-43.

  23. Ong S, Talan D et al and the Emergency ID NET Study Group 2. Neurocysticercosis in Radiographically Imaged Seizure Patients in USA. Emergency Departments 1 Emerging Infectious Diseases. Emerg Infec Dis 2002; 8(6): 608-613.

  24. Roberts T, Murrell KD, Marks S. Economic losses caused by food borne parasitic diseases. Parasitology Today 1994; 11: 419-23.

  25. Shorvon SD, Farmer PJ. Epilepsy in developing countries: a review of epidemiological, sociocultural and treatment aspects. Epilepsia 1988.

  26. Pal DK, Das T, Chaudhury G et al. Randomized controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India. Lancet 1998; 351: 19-23.

  27. Coleman R, Loppy L, Walraven G. The treatment gap and primary health care for people with epilepsy in rural Gambia. Bulletin of the World Health Organization 2002; 80: 378-383.

  28. Margono SS, Subahar R et al. Cysticercosis in Indonesia: epidemiological aspects. Southeast Asian J Trop Med Public Health 2001; 32(Suppl 2): 79-84.

  29. Cruz I et al. Neurocysticercosis: optimal dose treatment with albendazole. Jour of Neurol Sci 1995; 133: 152-154.

  30. Coleman R, Loppy L, Walraven G. Bulletin of the World Health Organization 2002; 80: 378-383.




2020     |     www.medigraphic.com